Should novobiocin be clinically re-evaluated?
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (4) , 363-365
- https://doi.org/10.1016/0732-8893(89)90105-3
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- In vitro evaluation of ramoplanin (A16686 or MDL62198): A new depsipeptide complex for potential topical useDiagnostic Microbiology and Infectious Disease, 1989
- In vitro activity of novobiocin and rifampin alone and in combination against oxacillin-resistant Staphylococcus aureusDiagnostic Microbiology and Infectious Disease, 1987
- Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combinationAntimicrobial Agents and Chemotherapy, 1986
- International Recognition of Methicillin-Resistant Strains of Staphylococcus aureusAnnals of Internal Medicine, 1982
- Observations Relating to an Inter-Hospital Outbreak of Methicillin-Resistant Staphylococcus aureus: Role of Antimicrobial Therapy in Infection ControlInfection Control, 1981
- Serious reactions to novobiocinThe Journal of Pediatrics, 1957
- Clinical and Laboratory Studies of Novobiocin, a New AntibioticArchives of internal medicine (1960), 1956